The Rome diagnostic criteria for the functional bowel disorders and functional abdominal pain are used widely in research and practice. A committee consensus approach, including criticism from multinational expert reviewers, was used to revise the diagnostic criteria and update diagnosis and treatment recommendations, based on research results. 
The functional bowel disorders and functional abdominal pain are common and cause much suVering. As these entities are identified by symptoms and patient care is highly individualized, a symptom-based classification has great importance, particularly for use in clinical trials (table 1) .
The 1998 Working Team assessed the terminology and results of relevant clinical research in order to revise the diagnostic criteria, comment further on diagnosis, and summarize treatment recommendations.
C. Functional bowel disorders
A functional bowel disorder (FBD) is a functional gastrointestinal disorder with symptoms attributable to the mid or lower gastrointestinal tract, including the irritable bowel syndrome (IBS), functional abdominal bloating, functional constipation, functional diarrhea, and unspecified functional bowel disorder.
Subjects with a FBD may be divided into the following groups:
Abbreviations used in this paper: FBD, functional bowel disorder; IBS, irritable bowel syndrome; FAPS, functional abdominal pain syndrome. The Working Team changed the definitions of IBS, functional abdominal bloating and functional constipation from a "disorder" to "disorders" to acknowledge multiple pathophysiologic possibilities. For IBS, "discomfort" was added to "pain" to broaden symptom description, and "distension" was deleted.
To clarify how discomfort and pain are temporally related to a change in frequency and form of stool, "onset" was added to the relevant symptom features. The symptom criteria for IBS were changed (a) by designating the nonpain-related, the second part of the previous criteria, as nonessential due to their poor clustering in factor analyses 1 2 ; (b) their lesser prevalence in men 3 ; and (c) the partial duplication in the retained, pain-related criteria. Furthermore, these symptoms were clarified by replacing the term "altered" with "abnormal." The criteria for functional constipation were expanded due to the overlap between it and the functional anorectal disorders (see Functional disorders of the anus and rectum).
C1. Irritable bowel syndrome
IBS comprises a group of functional bowel disorders in which abdominal discomfort or pain is associated with defecation or a change in bowel habit, and with features of disordered defecation.
Surveys of Western populations have revealed IBS in 15-20% of adolescents and adults, with a higher prevalence in women; the prevalence is variable in other populations. 4 IBS has a chronic relapsing course and overlaps with other functional gastrointestinal disorders. 5 It accounts for high direct medical expenses 6 and indirect costs, including absenteeism from work. 5 DIAGNOSTIC CRITERIA At least 12 weeks, which need not be consecutive, in the preceding 12 months of abdominal discomfort or pain that has two of three features:
(1) Relieved with defecation; and/or (2) Onset associated with a change in frequency of stool; and/or (3) Onset associated with a change in form (appearance) of stool.
The following symptoms cumulatively support the diagnosis of IBS: + abnormal stool frequency (for research purposes "abnormal" may be defined as >3/day and <3/week);
+ abnormal stool form (lumpy/hard or loose/ watery stool); + abnormal stool passage (straining, urgency, or feeling of incomplete evacuation); + passage of mucus; + bloating or feeling of abdominal distension.
These symptoms can be used to subclassify patients with predominant diarrhea or constipation for entry into clinical trials (table 2) .
DIAGNOSTIC COMMENTS
The validity of the symptom criteria is supported by patient studies, 3 7 8 factor analyses on non-patients 1 2 and long term patient follow up. 9 The history may also reveal postprandial symptom exacerbation, 10 and occasionally, incontinence and nocturnal pain. Symptom worsening during menses and other features can falsely suggest a gynecologic explanation for "chronic pelvic pain." 11 Other non-gastrointestinal somatic symptoms are common. 5 Colonic transit time can be estimated by rating self-reported stool appearance according to a stool form scale. 12 Fever, rectal bleeding, or weight loss require consideration of another disorder. 13 Abdominal examination reveals no abnormality. Large bowel structural examination is recommended to support a symptom-based diagnosis. The choice of such examinations should be guided by the age and gender of the patient, the nature and duration of symptoms, and other factors. 8 14 TREATMENT RECOMMENDATIONS A confident diagnosis, explanation, and reassurance are vital therapeutic tools. A graded, multicomponent approach is advised, depending on the dominant symptoms, their severity and psychosocial factors. 4 Although rigorous therapeutic trials are scarce, popular therapy includes the use increased dietary fiber such as wheat bran or bulking agents for constipation, loperimide or diphenoxylate for diarrhea, and anticholinergic/antispasmodic agents or lowdose antidepressants for pain. 4 Psychological or behavioral treatments may help some patients.
C2. Functional abdominal bloating
Functional abdominal bloating comprises a group of functional bowel disorders which are dominated by a feeling of abdominal fullness or bloating and without suYcient criteria for another functional gastrointestinal disorder.
Few studies adequately separate bloating from IBS and other functional disorders, but it occurs in about 15% of community-based There is no proved eVective therapy for functional bloating, and its cause is unknown, so only education and reassurance are recommended. The common practice of restricting certain "gas-forming" foods may be beneficial but even patients with confirmed lactase deficiency can drink 250 ml milk with no or negligible bloating.
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C3. Functional constipation
Functional constipation comprises a group of functional disorders which present as persistent diYcult, infrequent or seemingly incomplete defecation. Constipation occurs in up to 20% of populations, depending on demographic factors, sampling and the definition used. It is more common in women and is usually found to increase with age. defecations (e.g., digital evacuation, support of the pelvic floor); and/or (6) <3 defecations/week. Loose stools are not present, and there are insuYcient criteria for IBS.
DIAGNOSTIC COMMENTS
The physician should clarify what the patient means by constipation, as patients describe it in various ways. 19 Many, if not most patients actually have the rectal symptoms of IBS with or without lumpy stools. 20 Evaluation of the patient's general health, psychological status, use of constipating medications, dietary fiber intake, and medical illnesses (e.g., hypothyroidism) is important. In patients who do not respond to fiber supplementation, measurements of whole gut transit time 21 and anorectal function 22 may be indicated to place them in a physiological subgroup. TREATMENT 
RECOMMENDATIONS
Dietary fiber increases fecal bulk by providing indigestible matter and promoting fecal water holding and bacterial proliferation. 23 Other useful bulking agents include psyllium, methylcellulose, and calcium polycarbophil. Severely constipated patients may respond to polyethelene glycol solution. 24 Otherwise, stimulant laxatives such as bisacodyl, sodium picosulphate, or sennosides may be tried. Specific treatment for patients in the anorectal dysfunction subgroup is discussed in Functional disorders of the anus and rectum.
C4. Functional diarrhea
Functional diarrhea is continuous or recurrent passage of loose (mushy) or watery stools without abdominal pain.
A British population survey of stool form (a scale previously validated against symptoms and transit time 12 ) revealed liquid stools were the predominant type described by 5.3% of men and 4.3% of women. 25 Liquid stools were more common in women under 50 years of age than in older women. Pseudodiarrhea (frequent defecation and urgency with solid stools) must be distinguished from diarrhea. Chronic diarrhea without pain is caused by many diseases indistinguishable by history, which should be excluded by diagnostic testing. Basic evaluation includes routine blood and stool tests plus sigmoidoscopy with biopsy. Features atypical for a functional disorder (e.g., large volume stools, rectal bleeding, nutritional deficiency, and weight loss) call for more extensive studies of intestinal structure and function-for example, radiography, duodenal biopsy, and serum hormone assay.
TREATMENT RECOMMENDATIONS Discussion of possible psychosocial factors, symptom explanation, and reassurance are important. Restriction of foods which seem provocative may help. Empiric antidiarrheal therapy (e.g., diphenoxylate or loperimide) is usually eVective, especially if taken prophylactically, such as before meals. The occasional patient responds to cholestyramine. Fortunately, spontaneous remissions are common. 26 Functional
C5. Unspecified functional bowel disorder
An unspecified functional bowel disorder is defined as functional bowel symptoms that do not meet criteria for the previously defined categories.
D. Functional abdominal pain
Functional abdominal pain describes continuous, nearly continuous, or frequently recurrent pain localized in the abdomen but poorly related to gut function.
Functional abdominal pain is divided into two categories.
D1. Functional abdominal pain syndrome
Functional abdominal pain syndrome (FAPS), also called "chronic idiopathic abdominal pain" or "chronic functional abdominal pain," describes pain for at least six months that is poorly related to gut function and is associated with some loss of daily activities.
FAPS occurs in 1.7% of people, mainly women, and is associated with significant absenteeism from work and physician visits. Over time, patients with FAPS tend to have many specialist referrals, diagnostic tests and major abdominal and pelvic operations. Aspects of the patient's pain behavior are of primary importance. 27 Typically, the pain is described in emotional or bizarre terms, involves a large anatomic area, is associated with other painful symptoms, and is part of a continuum of painful experiences over many years. Usually, patients urgently report pain as extremely intense, and they request many diagnostic studies or surgery, focus primarily on the illness, and relentlessly seek pain relief and validation that the pain is "organic." They often ignore or deny a role for psychosocial contributions and absolve personal responsibility for self-management, while placing high expectations for relief on the physician. Pain behavior may diminish when the patient is distracted or not aware of being observed. A spouse or parent may be so aVected by the patient's illness as to report the history. Requests for narcotics are common. FAPS may co-exist with a structural disease (e.g., chronic pancreatitis) or FBD (e.g., IBS). The observation of a lack autonomic arousal, eye closure during abdominal examination, and diminished pain behavior with stethoscope application to the abdomen are typical. Multiple abdominal scars are common. TREATMENT 
RECOMMENDATIONS
Management depends on an eVective doctorpatient relationship, 27 including reasonable goals, regular appointments and, in some cases, concurrent psychological treatment. Analgesics are ineVective, and narcotics should be avoided. Concurrent depression should be treated. Low doses of antidepressants can reduce pain as well as insomnia. Anxiolytic therapy, if used at all, should be limited in duration. Various types of psychotherapy have been tried without critical evaluation. A multidisciplinary pain management program may be the most promising approach.
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D2. Unspecified functional abdominal pain
Unspecified functional abdominal pain is functional abdominal pain which fails to meet criteria for FAPS (D1).
For further information and updates on Rome II, visit our website at:
www.romecriteria.org 
